TP53 and hepatocellular carcinoma: In HCC, TP53 mutations correlate with a noninflamed TME and reduced survival of patients.84It has been shown that certain TP53 mutations can induce the Wnt/β-catenin pathway,85although the exact interplay of these pathways is still being studied.